YJYanbiao Jiang

Yanbiao Jiang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yanbiao Jiang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Ma

    Evidence‐Based Medicine Center, School of Basic Medical Sciences Lanzhou University Lanzhou People's Republic of China

    1 shared publication
  • Bin Wang

    The First Clinical Medical College Lanzhou University Lanzhou People's Republic of China

    1 shared publication
  • F Bian

    School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China

    1 shared publication
  • H X Yue

    School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China

    1 shared publication
  • Haofei Shen

    The First Clinical Medical College Lanzhou University Lanzhou People's Republic of China

    1 shared publication
  • Jianxiu Zheng

    The First Clinical Medical College Lanzhou University Lanzhou People's Republic of China

    1 shared publication

Latest Publications

  • The effect of embryo selection using time‐lapse monitoring on IVF/ICSI outcomes: A systematic review and meta‐analysis

    by Yanbiao Jiang, Liyan Wang, Sha Wang, Haofei Shen, Bin Wang, Jianxiu Zheng, Jinwei Yang, Bin Ma, Xuehong Zhang

    Aim: To explore the effect of embryo selection using the time‐lapse monitoring (TLM) system compared with conventional morphological selection (CMS) on in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) outcomes.Methods: We searched PubMed, Ovid‐Embase, and The Cochrane Library for the following studies: At Comparison 1, embryo selection using TLM images in a TLM incubator based on morphology versus embryo selection using CMS in a conventional incubator based on morphology; at Comparison 2, embryo selection using TLM based on morphokinetics versus embryo selection using CMS based on morphology. The primary outcomes were the live birth rate (LBR), ongoing pregnancy rate (OPR), clinical pregnancy rate (CPR), and implantation rate (IR), and the secondary outcome was the miscarriage rate (MR).Results: A total of 14 randomized control trials (RCTs) were included. Both based on morphology, TLM incubators increased the IR (risk ratio [RR]: 1.10; 95% confidence interval [CI]: 1.01, 1.18; I2 = 0%, moderate‐quality evidence) compared to conventional incubators. Low‐ to moderate‐quality evidence suggests that TLM incubators did not improve LBR, OPR, CPR, and MR compared to conventional incubators. In addition, low‐ to moderate‐quality evidence indicates that embryo selection using TLM based on morphokinetics did not improve LBR, OPR, CPR, IR, or MR compared to CMS based on morphology.Conclusions: Low‐ to moderate‐quality evidence suggests that neither TLM incubators nor embryo selection using TLM based on morphokinetics improved clinical outcomes (LBR, OPR, CPR, and MR) compared with CMS based on morphology. TLM is still an investigational procedure for IVF/ICSI practice.


  • [Application of AGREEⅡ in evaluating quality of esophageal cancer screening practice guidelines].

    by X Liu, Y F Zhang, Y L Zhan, H X Yue, L T Gui, F Bian, Y P Wang, Y Jiang

    High-quality clinical practice guidelines are of great significance for standardizing the clinical diagnosis and treatment process and improving the overall quality of health care. The Appraisal of Guidelines for Research & Evaluation InstrumentⅡ (AGREEⅡ) is one of the recognized tools for the evaluation of the quality of clinical practice guidelines. It has been translated into Chinese and is widely used in guideline formulation and quality evaluation. This article intends to take the comparatively high-quality clinical practice guidelines in the field of esophageal cancer screening in China, i.e. "Expert Consensus on Early Esophageal Cancer and Precancerous Lesion Screening in China (2019, Xinxiang)" as an example, to interpret the use of AGREEⅡ item by item, which might provide a reference for medical and health workers to better understand and use the assessment tool.